nach oben

01.08.2011 | Pictorial Review | Ausgabe 4/2011 Open Access

Part 1: CT characterisation of pancreatic neoplasms: a pictorial essay

Zeitschrift:: Insights into Imaging > Ausgabe 4/2011

Autoren:: Angela Galvin, Tom Sutherland, Andrew F. Little

» Zum Volltext PDF-Version jetzt herunterladen

Abstract

The pancreas is a site of origin of a diverse range of benign and malignant tumours, and these are frequently detected, diagnosed and staged with computed tomography (CT). Knowledge of the typical appearance of these neoplasms as well as the features of locoregional invasion is fundamental for all general and abdominal radiologists. This pictorial essay aims to outline the characteristic CT appearances of the spectrum of pancreatic neoplasms, as well as important demographic and clinical information that aids diagnosis. The second article in this series addresses common mimics of pancreatic neoplasia.

Winter TC, Ager JD, Nghiem HV et al (1996) Upper gastrointestinal tract and abdomen: water as an orally administered contrast agent for helical CT. Radiology 201:365–370 PubMedCrossRef

Sener SF, Fremgen A, Menck HR, Winchester DP (1999) Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985–1995, using the National Cancer Database. J Am Col Surg 189(1):1–7 CrossRef

Klauss M, Alt CD, Welzel T et al (2009) Multidectector CT evaluation of the course of nonresectable pancreatic carcinomas with neoadjuvant therapy. Pancreatology 9:621–630 PubMedCrossRef

Gangi S, Fletcher JG, Nathan MA et al (2004) Time interval between abnormalities seen on CT and the clinical diagnosis of pancreatic cancer: retrospective review of CT scans obtained before diagnosis. AJR Am J Roentgenol 182:897–903 PubMedCrossRef

McNulty NJ, Francis IR, Cohan RH et al (2001) Multi-detector row helical CT of the pancreas: effect of contrast-enhanced multiphase imaging on enhancement of the pancreas, peripancreatic vasculature, and pancreatic adenocarcinoma. Radiology 220:97–102 PubMedCrossRef

Deshmukh SD, Willmann JK, Jeffrey RB (2010) Pathways of extrapancreatic perineural invasion by pancreatic adenocarcinoma: evaluation with 3D volume-rendered MDCT imaging. AJR Am J Roentgenol 194:668–674 PubMedCrossRef

Bluemke DA, Cameron JL, Hruban RH et al (1995) Potentially resectable pancreatic adenocarcinoma: spiral CT assessment with surgical and pathologic correlation. Radiology 197:381–385 PubMedCrossRef

Tabuchi T, Itoh K, Ohshio G (1999) Tumor staging of pancreatic adenocarcinoma using early- and late-phase helical CT. AJR Am J Roentgenol 173:375–380 PubMedCrossRef

Sai M, Mori H, Kiyonaga M et al (2010) Peripancreatic lymphatic invasion by pancreatic carcinoma: multi-detector row CT. Abdom Imaging 35(2):154–162 PubMedCrossRef

10.

Horton KM, Fishman EK (2002) Multidetector CT angiography of pancreatic carcinoma: part 2, evaluation of venous involvement. AJR Am J Roentgenol 178:833–836 PubMedCrossRef

11.

Horton KM, Fishman EK (2002) Multidetector CT angiography of pancreatic carcinoma: part 1, evaluation of arterial involvement. AJR Am J Roentgenol 178:827–831 PubMedCrossRef

12.

Phoa SSKS, Reeders JWAJ, Stoker J et al (2000) CT criteria for venous invasion in patients with pancreatic head carcinoma. Br J Radiol 73:1159–1164 PubMedCrossRef

13.

Li H, Zeng MS, Zhou KR et al (2005) Pancreatic adenocarcinoma: the different ct criteria for peripancreatic major arterial and venous invasion. J Comput Assist Tomogr 29:170–175 PubMedCrossRef

14.

Lu DSK, Reber HA, Krasny RM et al (1997) Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT. AJR Am J Roentgenol 168:1439–1443 PubMedCrossRef

15.

Bipat S, Phoa SSKA, van Delden OM et al (2005) Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis and determining resectability of pancreatic adenocarcinoma: a meta-analysis. J Comput Assist Tomogr 29:438–445 PubMedCrossRef

16.

Zamboni GA, Kruskal JB, Vollmer CM et al (2007) Pancreatic adenocarcinoma: value of multidetector CT angiography in preoperative evaluation. Radiology 245(3):770–778 PubMedCrossRef

17.

Sahani DV, Shah ZK, Cataloano OF et al (2008) Radiology of pancreatic adenocarcinoma: current status of imaging. J Gastroenterol Hepatol 23(1):23–33 PubMedCrossRef

18.

Ng DZW, Goh BKP, Tham EHW et al (2009) Cystic neoplasms of the pancreas: current diagnostic modalities and management. Ann Acad Med Singapore 38:251–259 PubMed

19.

Buck JL (1990) Hayes DO (1983) Microcystic adenoma of the pancreas. Radiographics 10:313–322 PubMedCrossRef

20.

Friedman AC, Lichtenstein JE, Dachman AH (1983) Cystic neoplasms of the pancreas. Radiology 149:45–50 PubMedCrossRef

21.

Khurana B, Mortele KJ, Glickman J et al (2003) Macrocystic serous adenoma of the pancreas; radiologic-pathologic correlation. AJR Am J Roentgenol 181:119–123 PubMedCrossRef

22.

De Lima JE, Javitt MC, Mathur SC (1999) Mucinous cystic neoplasm of the pancreas. Radiographics 19:807–811 PubMedCrossRef

23.

Buetow PC, Rao P, Thompson LDR (1998) Mucinous cystic neoplasms of the pancreas: radiologic-pathologic correlation. Radiographics 18:433–449 PubMedCrossRef

24.

Baiocchi GL, Portolani N, Missale G et al (2010) Intraductal papillary mucinous neoplasm of the pancreas (IPMN): clinico-pathological correlations and surgical indications. World J Surg Oncol 8:25 PubMedPubMedCentralCrossRef

25.

Waters JA, Schmidt CM, Pinchot JW et al (2008) CT vs MRCP: optimal classification of IPMN type and extent. J Gastrointest Surg 12:1010–1109

26.

Lim JH, Lee G, Oh YL (2001) Radiologic spectrum of intraductal papillary mucinous tumour of the pancreas. Radiographics 21:323–340 PubMedCrossRef

27.

Song SJ, Lee JM, Kim YJ et al (2007) Differentiation of intraductal papillary mucinous neoplasms from other pancreatic cystic masses: comparison of multirow-detector CT and MRI imaging using ROC analysis. J Magn Reson Imaging 26(1):86–93 PubMedCrossRef

28.

Procacci C, Megibow AJ, Carbognin G et al (1999) Intraductal papillary mucinous tumour of the pancreas: a pictorial essay. Radiographics 19:1447–1463 PubMedCrossRef

29.

Tanaka M, Chari S, Adsay V et al (2006) International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 6:17–32 PubMedCrossRef

30.

Patil TB, Shrikhande V, Kanhere A et al (2006) Solid pseudopapillary neoplasm of the pancreas: a single institution experience of 14 cases. HPB 8:148–150 PubMedPubMedCentralCrossRef

31.

Sperti C, Berselli M, Pasquali C et al (2008) Aggressive behaviours of solid-pseudopapillary tumor of the pancreas in adults: a case report and review of the literature. World J Gastroenterol 14(6):960–965 PubMedPubMedCentralCrossRef

32.

Kamat RN, Naik LD, Joshi RM et al (2008) Solid pseudopapillary tumour of the pancreas. Indian J Pathol Microbiol 51:271–273 PubMedCrossRef

33.

Coleman KM, Doherty MC, Bigler SA (2003) Solid-pseudopapillary tumor of the pancreas. Radiographics 23:1644–1648 PubMedCrossRef

34.

Choi JY, Kim MJ, Kim SH et al (2006) Solid pseudopapillary tumor of the pancreas: typical and atypical manifestations. AJR Am J Roentgenol 187:178–186 CrossRef

35.

Dong DJ, Zhang SZ (2006) Solid-pseudopapillary tumor of the pancreas: CT and MRI features of 3 cases. Hepatobiliary Pancreat Dis Int 5:300–304 PubMed

36.

Lee DS, Jeffrey RB, Kamaya A (2009) Islet-cell tumors of the pancreas: spectrum of MDCT findings: a pictorial essay. Appl Radiol 38:10–28

37.

Halfdanarson TR, Rabe KG, Rubin J, Petersen GM (2008) Pancreatic neuroendocrine tumors (PNETS): incidence, prognosis and recent trend toward improved survival. Ann Oncol 19:1727–1733 PubMedPubMedCentralCrossRef

38.

Kazanjian KK, Reber HA, Hines OJ (2006) Resection of pancreatic neuroendocrine tumors: results of 70 cases. Arch Surg 141:765–770 PubMedCrossRef

39.

Horton KM, Hruban RH, Yeo C (2006) Multi-detector row CT of pancreatic islet cell tumors. Radiographics 26:453–464 PubMedCrossRef

40.

Schindl M, Kaczirek K, Kaserer K, Niederle B (2000) Is the new classification of neuroendocrine pancreatic tumors of clinical help? World J Surg 24:1312–1318 PubMedCrossRef

41.

Merkle EM, Bender GN, Brambs HJ (2000) Imaging findings in pancreatic lymphoma: differential aspects. AJR Am J Roentgenol 174:671–675 PubMedCrossRef

42.

Prayer L, Schurawitzki H, Malleck R, Mostbeck G (1992) CT in pancreatic involvement of non-Hodgkin lymphoma. Acta Radiol 33:123–127 PubMedCrossRef

43.

Scartarige JC, Horton KM, Sheth S et al (2001) Pancreatic parenchymal metastases: observation on helical CT. AJR Am J Roentgenol 176:695–699 CrossRef

44.

Merkle EM, Boaz T, Kolokythas O et al (1998) Metastases to the pancreas. Br J Radiol 71:1208–1214 PubMedCrossRef

Titel: Part 1: CT characterisation of pancreatic neoplasms: a pictorial essay
Autoren:: Angela Galvin
Tom Sutherland
Andrew F. Little
Publikationsdatum: 01.08.2011
DOI: https://doi.org/10.1007/s13244-011-0102-7
Verlag: Springer Berlin Heidelberg
Zeitschrift: Insights into Imaging
Ausgabe 4/2011
Elektronische ISSN: 1869-4101

Neu im Fachgebiet Radiologie

19.10.2020 | COVID-19 | Nachrichten

Newsletter bestellen

Bildnachweise

Mail Icon II

Part 1: CT characterisation of pancreatic neoplasms: a pictorial essay

Abstract

Wie gefährlich wird COVID-19 im Winter?

Was das Brustkrebsrisiko bei gutartigem Befund steigen lässt

Was kostet Corona das Gesundheitswesen?

Aufschub für CME-Punktenachweis nochmals verlängert

Newsletter

Springer Medizin

Abstract

Weitere Artikel der Ausgabe 4/2011

Lean manufacturing and Toyota Production System terminology applied to the procurement of vascular stents in interventional radiology

Left ventricular apical diseases

Pseudotumoural soft tissue lesions of the foot and ankle: a pictorial review

Ultrasound-guided core-needle biopsy of breast lesions

The emerging role of magnetic resonance imaging and multidetector computed tomography in the diagnosis of dilated cardiomyopathy

Part 2: CT characterisation of pancreatic neoplasm: tumour mimics

Neu im Fachgebiet Radiologie

Wie gefährlich wird COVID-19 im Winter?

Was das Brustkrebsrisiko bei gutartigem Befund steigen lässt

Was kostet Corona das Gesundheitswesen?

Aufschub für CME-Punktenachweis nochmals verlängert

Newsletter